Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/9/23 16:10 | 8/7/23 | VTGN | Health | Drug | Pharmaceutical Preparations | Commodore Capital LP | NY | T | P | 17,961 | 23.15 | 0 | 776 | 97 | 1,575 | I | |||||||||||||||
8/22/22 17:12 | 8/18/22 | VTGN | Health | Drug | Pharmaceutical Preparations | Gin Jerry B | CA | D | P | 36 | 0.1787 | 0 | 200 | 100 | 400 | M | |||||||||||||||
8/19/22 15:45 | 8/17/22 | VTGN | Health | Drug | Pharmaceutical Preparations | Adler Reid G. | CA | O | GC | P | 51 | 0.1697 | 0 | 300 | 866 | 335 | D | ||||||||||||||
8/18/22 15:56 | 8/17/22 | VTGN | Health | Drug | Pharmaceutical Preparations | Singh Shawn | CA | DO | CEO | P | 103 | 0.1720 | 0 | 600 | 333 | 780 | I | ||||||||||||||
7/14/22 17:33 | 7/12/22 | VTGN | Health | Drug | Pharmaceutical Preparations | Venrock Healthcare Capital Partners Ii, L.P. | CA | T | S | -53 | 0.8900 | 0 | -60 | 0 | 20,637 | I | |||||||||||||||
5/16/22 13:39 | 5/12/22 | VTGN | Health | Drug | Pharmaceutical Preparations | Singh Shawn | CA | DO | CEO | M.d | 100 | 1.00 | 0 | 100 | 133 | 175 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |